RFP QuestBeta
ClosedStage · contract

Public Health England

PHE_Scientific_Development of an Ovine Polyclonal Immunoglobulin Therapy.

ChemicalsCPV 24956000
Value£27k
Deadline16 Apr 2020
Published9 Feb 2021
RegionSouth West
Timeline
Published 9 Feb 2021ClosedCloses 16 Apr 2020
Contract value in context
£27ktotal contract value
median £101k
this tender£0£6.4m

This sits below the typical range for Chemical Products contracts — a smaller, more accessible award. Based on 1,041 valued Chemical Products tenders in our corpus.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

This requirement was to develop a rapid and effective therapy against infection by developing an ovine immunoglobulin treatment against the spike protein of Covid 19.

Buyer intelligence

Make the case to bid

Reveal who to approach at Public Health England, and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
944834b2-12a7-4e1a-b7b5-e976a2fe12f8
Stage
contract · Contract
Source
Contracts Finder
Buyer ref
tender_238185/924262
View the original notice on Contracts Finder

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Chemical Products

Assembling the market network…

Public Health England’s tender network

Assembling the network…